| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |